HKSE:02480 (China)
Â
H share
HK$
13
+0.10 (+0.78%)
Jul 17
Business Description
Beijing Luzhu Biotechnology Co Ltd
ISIN : CNE100005YD8
Share Class Description:
HKSE:02480: H shareTotal Employee Number:
193Compare
Compare
Traded in other countries / regions
02480.Hong Kong IPO Date
2023-05-05Description
Beijing Luzhu Biotechnology Co., Ltd. is a biotechnology company committed to developing human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Group's product pipeline consisted of three clinical-stage product candidates, including its Core Product, LZ901, and six pre-clinical-stage product candidates.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.54 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | -1.91 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 45.9 | |||||
3-Year EPS without NRI Growth Rate | 41.6 | |||||
3-Year FCF Growth Rate | 17 | |||||
3-Year Book Growth Rate | -10.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 90.63 | |||||
9-Day RSI | 49.54 | |||||
14-Day RSI | 30.12 | |||||
3-1 Month Momentum % | -44.52 | |||||
6-1 Month Momentum % | -45.97 | |||||
12-1 Month Momentum % | -43.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.7 | |||||
Quick Ratio | 3.67 | |||||
Cash Ratio | 3.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | -6.65 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -20.24 | |||||
ROA % | -14.39 | |||||
ROIC % | -23.22 | |||||
3-Year ROIIC % | 16.74 | |||||
ROC (Joel Greenblatt) % | -24.74 | |||||
ROCE % | -15.28 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 3.55 | |||||
Price-to-Tangible-Book | 3.59 | |||||
EV-to-EBIT | -15.3 | |||||
EV-to-EBITDA | -15.3 | |||||
EV-to-FCF | -11.57 | |||||
| Price-to-Net-Current-Asset-Value | 39.39 | |||||
| Price-to-Net-Cash | 59.09 | |||||
Earnings Yield (Greenblatt) % | -6.54 | |||||
FCF Yield % | -8.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Luzhu Biotechnology Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | |||
| EPS (TTM) (HK$) | -0.824 | ||
| Beta | 0.385 | ||
| 3-Year Sharpe Ratio | -0.48 | ||
| 3-Year Sortino Ratio | -0.68 | ||
| Volatility % | 43.5 | ||
| 14-Day RSI | 30.12 | ||
| 14-Day ATR (HK$) | 0.13476 | ||
| 20-Day SMA (HK$) | 12.7915 | ||
| 12-1 Month Momentum % | -43.33 | ||
| 52-Week Range (HK$) | 12 - 28 | ||
| Shares Outstanding (Mil) | 198.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Luzhu Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Luzhu Biotechnology Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Luzhu Biotechnology Co Ltd Frequently Asked Questions
What is Beijing Luzhu Biotechnology Co Ltd(HKSE:02480)'s stock price today?
The current price of HKSE:02480 is HK$13.00. The 52 week high of HKSE:02480 is HK$28.00 and 52 week low is HK$12.00.
When is next earnings date of Beijing Luzhu Biotechnology Co Ltd(HKSE:02480)?
The next earnings date of Beijing Luzhu Biotechnology Co Ltd(HKSE:02480) is .
Does Beijing Luzhu Biotechnology Co Ltd(HKSE:02480) pay dividends? If so, how much?
Beijing Luzhu Biotechnology Co Ltd(HKSE:02480) does not pay dividend.
Articles on Beijing Luzhu Biotechnology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers